Advisor Group Holdings »

Sonnet Biotherapeutc Hldng I shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $77 45 1.73
2023-09-30 $129 45 2.87

More positions owned by Advisor Group Holdings

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
NVIDIA Corporation (NVDA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Total Usd (IUSB)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Advisor Group Holdings

Top funds holding Sonnet Biotherapeutc Hldng I

Citadel Advisors
Vanguard Group
Advisor Group Holdings
Wells Fargo & Company
Jpmorgan Chase & Co
Private Wealth Management Group

View all funds holding Sonnet Biotherapeutc Hldng I